Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
30 June 2016Website:
http://www.xeneticbio.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | 13 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is Xenetic Biosciences?
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
What sector is Xenetic Biosciences in?
Xenetic Biosciences is in the Healthcare sector
What industry is Xenetic Biosciences in?
Xenetic Biosciences is in the Biotechnology industry
What country is Xenetic Biosciences from?
Xenetic Biosciences is headquartered in United States
When did Xenetic Biosciences go public?
Xenetic Biosciences initial public offering (IPO) was on 30 June 2016
What is Xenetic Biosciences website?
https://www.xeneticbio.com
Is Xenetic Biosciences in the S&P 500?
No, Xenetic Biosciences is not included in the S&P 500 index
Is Xenetic Biosciences in the NASDAQ 100?
No, Xenetic Biosciences is not included in the NASDAQ 100 index
Is Xenetic Biosciences in the Dow Jones?
No, Xenetic Biosciences is not included in the Dow Jones index
When does Xenetic Biosciences report earnings?
Next earnings report date is not announced yet